{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:25:18Z","timestamp":1767180318505,"version":"build-2238731810"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003516","name":"Winn Feline Foundation","doi-asserted-by":"publisher","award":["16-023"],"award-info":[{"award-number":["16-023"]}],"id":[{"id":"10.13039\/100003516","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Companion Animal Health Foundation","award":["005\/2016"],"award-info":[{"award-number":["005\/2016"]}]},{"name":"Feline Health Research Foundation Australia","award":["USyd IRMA 183456"],"award-info":[{"award-number":["USyd IRMA 183456"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230975","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T13:29:49Z","timestamp":1586870989000},"page":"e0230975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["In vitro hepatic metabolism of mefloquine using microsomes from cats, dogs and the common brush-tailed possum (Trichosurus vulpecula)"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-384X","authenticated-orcid":true,"given":"Aaron Michael","family":"Izes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Kimble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline Marie","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3595-0500","authenticated-orcid":true,"given":"Merran","family":"Govendir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"pone.0230975.ref001","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jfms.2009.05.008","article-title":"Feline infectious peritonitis. ABCD guidelines on prevention and management.","volume":"11","author":"D Addie","year":"2009","journal-title":"J Feline Med Surg"},{"key":"pone.0230975.ref002","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jfms.2008.09.008","article-title":"A review of feline infectious peritonitis virus infection: 1963\u20132008.","volume":"11","author":"NC Pedersen","year":"2009","journal-title":"J Feline Med Surg"},{"key":"pone.0230975.ref003","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0034-5288(93)90076-R","article-title":"Evaluation of free or liposome-encapsulated ribavirin for antiviral therapy of experimentally induced feline infectious peritonitis","volume":"55","author":"R Weiss","year":"1993","journal-title":"Res Vet Sci"},{"key":"pone.0230975.ref004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vetmic.2018.04.026","article-title":"The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.","volume":"219","author":"BG Murphy","year":"2018","journal-title":"Vet Microbiol"},{"key":"pone.0230975.ref005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1098612X19825701","article-title":"Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis.","volume":"21","author":"NC Pedersen","year":"2019","journal-title":"J Feline Med Surg"},{"key":"pone.0230975.ref006","article-title":"Mefloquine for preventing malaria in pregnant women.","author":"R Gonz\u00e1lez","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"pone.0230975.ref007","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-9-357","article-title":"The position of mefloquine as a 21 st century malaria chemoprophylaxis.","volume":"9","author":"P Schlagenhauf","year":"2010","journal-title":"Malar J."},{"key":"pone.0230975.ref008","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bjid.2016.07.005","article-title":"Gomes MdSM. Patient age does not affect mefloquine concentrations in erythrocytes and plasma during the acute phase of falciparum malaria","volume":"20","author":"JLF Vieira","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"pone.0230975.ref009","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.vetmic.2015.02.007","article-title":"Antiviral effect of mefloquine on feline calicivirus in vitro","volume":"176","author":"P McDonagh","year":"2015","journal-title":"Vet Microbiol"},{"key":"pone.0230975.ref010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.vetmic.2014.10.030","article-title":"Identification and characterisation of small molecule inhibitors of feline coronavirus replication","volume":"174","author":"P McDonagh","year":"2014","journal-title":"Vet Microbiol"},{"key":"pone.0230975.ref011","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0024-3205(00)00546-4","article-title":"Role of cytochrome P450 3A in the metabolism of mefloquine in human and animal hepatocytes","volume":"66","author":"F Fontaine","year":"2000","journal-title":"Life Sci"},{"key":"pone.0230975.ref012","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(09)70320-2","article-title":"Pharmacogenetics of antimalarial drugs: effect on metabolism and transport","volume":"9","author":"R Kerb","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"pone.0230975.ref013","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cvsm.2013.05.002","article-title":"Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.","volume":"43","author":"MH Court","year":"2013","journal-title":"Vet Clin North Am Small Anim Pract."},{"key":"pone.0230975.ref014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/jvp.12338","article-title":"Comparative metabolism of mycophenolic acid by glucuronic acid and glucose conjugation in human, dog, and cat liver microsomes","volume":"40","author":"JE Slovak","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"key":"pone.0230975.ref015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cbpc.2013.12.002","article-title":"In vitro hepatic microsomal metabolism of meloxicam in koalas (Phascolarctos cinereus), brushtail possums (Trichosurus vulpecula), ringtail possums (Pseudocheirus peregrinus), rats (Rattus norvegicus) and dogs (Canis lupus familiaris).","volume":"161","author":"B Kimble","year":"2014","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"pone.0230975.ref016","first-page":"7.8.1","article-title":"In vitro drug metabolism using liver microsomes","volume":"23","author":"JR Hill","year":"2003","journal-title":"Curr Protoc Pharmacol"},{"key":"pone.0230975.ref017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"pone.0230975.ref018","first-page":"1350","article-title":"Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes","volume":"27","author":"RS Obach","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"pone.0230975.ref019","unstructured":"Izes AM. Comparative studies of in vitro hepatic metabolism of mefloquine by feline microsomes and those of other selected species: The University of Sydney; 2019. https:\/\/ses.library.usyd.edu.au\/handle\/2123\/21353;oai:ses.library.usyd.edu.au:2123\/21353"},{"key":"pone.0230975.ref020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1208\/s12248-014-9691-7","article-title":"Addressing the challenges of low clearance in drug research.","volume":"17","author":"L Di","year":"2015","journal-title":"AAPS J."},{"key":"pone.0230975.ref021","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2174\/138920007782798207","article-title":"The conduct of drug metabolism studies considered good practice (II): in vitro experiments.","volume":"8","author":"L Jia","year":"2007","journal-title":"Curr Drug Metab."},{"key":"pone.0230975.ref022","first-page":"1","article-title":"Intrinsic clearance rate of O-desmethyltramadol (M1) by glucuronide conjugation and phase I metabolism by feline, canine and common brush-tailed possum microsomes.","volume":"2019","author":"AM Izes","journal-title":"Xenobiotica"},{"key":"pone.0230975.ref023","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/FPC.0000000000000057","article-title":"PharmGKB summary: tramadol pathway.","volume":"24","author":"L Gong","year":"2014","journal-title":"Pharmacogenet Genom"},{"key":"pone.0230975.ref024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-2875-11-59","article-title":"A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.","volume":"11","author":"GO Gbotosho","year":"2012","journal-title":"Malar J."},{"key":"pone.0230975.ref025","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jac\/dku154","article-title":"Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso","volume":"69","author":"I Valea","year":"2014","journal-title":"J Antimicrobial Chemotherapy"},{"key":"pone.0230975.ref026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jchromb.2013.11.035","article-title":"Simultaneous quantification of mefloquine (+)- and (-)-enantiomers and the carboxy metabolite in dried blood spots by liquid chromatography\/tandem mass spectrometry.","volume":"968","author":"MC Geditz","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"pone.0230975.ref027","unstructured":"International Conference on Harmonisation, editor ICH Harmonised tripartite guideline: Validation of analytical procedures: Text and methodology Q2(R1). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2005; Geneva, Switzerland"},{"key":"pone.0230975.ref028","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0006-2952(88)90723-X","article-title":"Disposition of the antimalarial, mefloquine, in the isolated perfused rat liver","volume":"37","author":"MD Coleman","year":"1988","journal-title":"Biochemical Pharmacol"},{"key":"pone.0230975.ref029","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0006-2952(97)00072-5","article-title":"Molecular basis for deficient acetaminophen glucuronidation in cats. An interspecies comparison of enzyme kinetics in liver microsomes","volume":"53","author":"MH Court","year":"1997a","journal-title":"Biochem Pharmacol"},{"key":"pone.0230975.ref030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.2042-7158.1997.tb06822.x","article-title":"Biochemical basis for deficient paracetamol glucuronidation in cats: an interspecies comparison of enzyme constraint in liver microsomes","volume":"49","author":"MH Court","year":"1997b","journal-title":"J Pharm Pharmacol"},{"issue":"7","key":"pone.0230975.ref031","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1359-6446(03)03019-8","article-title":"Strategies for using in vitro screens in drug metabolism","volume":"9","author":"N Plant","year":"2004","journal-title":"Drug Discovery Today"},{"key":"pone.0230975.ref032","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/dmd.111.043117","article-title":"Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.","volume":"40","author":"RL Walsky","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"pone.0230975.ref033","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2885.2007.00902.x","article-title":"Characterization of cytochrome P450\u2010mediated drug metabolism in cats","volume":"30","author":"S Shah","year":"2007","journal-title":"J Vet Pharmacol Ther"},{"key":"pone.0230975.ref034","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tmaid.2014.10.021","article-title":"Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports.","volume":"13","author":"\u00c5 Ringqvist","year":"2015","journal-title":"Travel Med Infect Di"},{"key":"pone.0230975.ref035","first-page":"224","article-title":"Psychiatric side effects of mefloquine: applications to forensic psychiatry.","volume":"41","author":"EC Ritchie","year":"2013","journal-title":"J Am Acad Psychiatry"},{"key":"pone.0230975.ref036","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.bjp.0703638","article-title":"The antimalarial agent mefloquine inhibits ATP\u2010sensitive K\u2010channels.","volume":"131","author":"FM Gribble","year":"2000","journal-title":"Brit J Pharmacol"},{"key":"pone.0230975.ref037","doi-asserted-by":"crossref","first-page":"e0168780","DOI":"10.1371\/journal.pone.0168780","article-title":"Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.","volume":"12","author":"SJ Lee","year":"2017","journal-title":"PloS One"},{"key":"pone.0230975.ref038","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2165\/00003088-199019040-00002","article-title":"Clinical pharmacokinetics of mefloquine.","volume":"19","author":"J Karbwang","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"pone.0230975.ref039","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/clinids\/18.2.263","article-title":"Aplastic anemia during malarial prophylaxis with mefloquine","volume":"18","author":"AR Stracher","year":"1994","journal-title":"Clin Infect Dis"},{"key":"pone.0230975.ref040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2230.1999.00471.x","article-title":"Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports","volume":"24","author":"H Smith","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"pone.0230975.ref041","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00003088-198510030-00001","article-title":"Clinical pharmacokinetics of antimalarial drugs.","volume":"10","author":"NJ White","year":"1985","journal-title":"Clin Pharmacokinet"},{"key":"pone.0230975.ref042","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cpt1979263372","article-title":"Kinetics of a new antimalarial, mefloquine","volume":"26","author":"R Desjardins","year":"1979","journal-title":"Clin Pharmacol Ther"},{"key":"pone.0230975.ref043","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1472-8206.1994.tb00830.x","article-title":"Clinical application of mefloquine pharmacokinetics in the treatment of P. falciparum malaria.","volume":"8","author":"J Karbwang","year":"1994","journal-title":"Fundam Clin Pharm"},{"key":"pone.0230975.ref044","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03190836","article-title":"Mefloquine disposition in normals and in patients with severe Plasmodium falciparum malaria.","volume":"14","author":"F Juma","year":"1989","journal-title":"Eur J Drug Metab Ph"},{"key":"pone.0230975.ref045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1094-9194(17)30156-1","article-title":"Emergency care of raptors.","volume":"1","author":"V Joseph","year":"1998","journal-title":"Vet Clin North Am Exotic An Pract"},{"key":"pone.0230975.ref046","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro.","volume":"53","author":"M Brickelmaier","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0230975.ref047","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1124\/jpet.105.086272","article-title":"In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine","volume":"314","author":"A Owen","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0230975.ref048","doi-asserted-by":"crossref","first-page":"e1005531","DOI":"10.1371\/journal.ppat.1005531","article-title":"Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor.","volume":"12","author":"Y Kim","year":"2016","journal-title":"PLoS Pathog."}],"updated-by":[{"DOI":"10.1371\/journal.pone.0233223","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T13:30:10Z","timestamp":1586871010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230975"}},"subtitle":[],"editor":[{"given":"Carlos E.","family":"Ambr\u00f3sio","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]}}}